GCA
KITE

Gideon Capital Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Gideon Capital Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,880
Closed -$338K – 459
2017
Q3 		$338K Buy
+1,880
New +$262K 0.33% 108

Gideon Capital Advisors's KITE Position: Q4 2017 in Review

Gideon Capital Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,880 shares — an estimated $338K sold.

Gideon Capital Advisors first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $338K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Gideon Capital Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gideon Capital Advisors sold 1,880 Kite Pharma, Inc. shares in Q4 2017, an estimated $338K.
  • Gideon Capital Advisors first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Gideon Capital Advisors's Kite Pharma, Inc. position peaked at $338K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Gideon Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.